SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000919574-19-000663
Filing Date
2019-01-29
Accepted
2019-01-29 16:22:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8180923_13-g.htm SC 13G 120849
  Complete submission text file 0000919574-19-000663.txt   122312
Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2463
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89137 | Film No.: 19548949
SIC: 2834 Pharmaceutical Preparations